Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys
King's College London · London School of Economics and Political Science · +43 more institutions
Abstract
The treatment gap between the number of people with mental disorders and the number treated represents a major public health challenge. We examine this gap by socio-economic status (SES; indicated by family income and respondent education) and service sector in a cross-national analysis of community epidemiological survey data.
Data come from 16 753 respondents with 12-month DSM-IV disorders from community surveys in 25 countries in the WHO World Mental Health Survey Initiative. DSM-IV anxiety, mood, or substance disorders and treatment of these disorders were assessed with the WHO Composite International Diagnostic Interview (CIDI).
Citation impact
- FWCI
- 10.78
- Percentile
- 100%
- References
- 35
Authors
32- SESara Evans‐Lacko
King's College London, London School of Economics and Political Science
- SASergio Aguilar‐Gaxiola
UC Davis Health
- AAA. Al-Hamzawi
University of Al-Qadisiyah
- JAJordi Alonso
Universitat Pompeu Fabra, Hospital Del Mar, Municipal Institute for Medical Research, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Hospital del Mar Research Institute
- CBCorina Benjet
Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
Topics & keywords
- CIDI
- Mental health
- Psychiatry
- Anxiety
- Public health
- Respondent
- Mood
- Psychology
Funding
- RWRobert Wood Johnson FoundationAwards: 044708, Grant 044708
- JDJohn D. and Catherine T. MacArthur FoundationAwards: R01 DA016558, R13-MH066849
- JWJohn W. Alden Trust
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- WHWorld Health Organization
- UOUniversity of Michigan
- SLSouth London and Maudsley NHS Foundation Trust
- KCKing's College Hospital NHS Foundation Trust
- UCUniversidad CES
- NINational Institute for Health and Care ResearchAward: FP7/2007-2013
- KCKing's College London
- ECEuropean CommissionAwards: EAHC 20081308, 20081308, FP7/2007-2013, 337673, QLG5-1999-01042, 2004123, 2007-2013, FP7/2007, SANCO 2004123
- PHPublic Health Agency
- FDFundação de Amparo à Pesquisa do Estado de São PauloAwards: 03/00204-3, 03/00204-
- GDGeneralitat de CatalunyaAward: 01042
- BFBundesministerium für Gesundheit
- NINational Insurance Institute of Israel
- MOMinistry of Health, Labour and WelfareAward: H25-SEISHIN-IPPAN-006
- UDUniversidade de Lisboa
- MDMinisterio de Ciencia y TecnologíaAward: SAF 2000-158-CE
- FPFundación para la Formación e Investigación Sanitarias de la Región de Murcia
- SMServicio Murciano de Salud
- RPRegione PiemonteAward: 00/0028
- FMFakultet Medicinskih Nauka, Univerziteta U Kragujevcu
- SServier
- HLH. Lundbeck A/S
- FCFundação ChampalimaudAward: R01 MH070884
- MDMinisterio de Salud
- MZMinisterstwo Zdrowia
- SASubstance Abuse and Mental Health Services Administration
- UPU.S. Public Health ServiceAwards: R01 DA016558, R01-MH069864, R13-MH066849
- PFPfizer FoundationAwards: R01-MH069864, R01 DA016558, R13-MH066849, R03-TW006481
- PAPan American Health Organization
- EAExecutive Agency for Health and Consumers
- FPFundação para a Ciência e a Tecnologia
- IDInstituto de Salud Carlos IIIAwards: CB06/02/0046, RETICS RD06/0011, RD06/0011, FIS 00/0028, CIBER CB06/02/0046
- NGNorway Grants
- CDConsejería de Sanidad y Política Social, Comunidad Autónoma de la Región de Murcia
- DDDepartament de Salut, Generalitat de Catalunya
- NINational Institute of Mental HealthAwards: U01-MH60220, R01-MH069864, MH60220, MH070884, R01 MH070884, R13-MH066849
- NINational Institute on Drug AbuseAward: R01 DA016558
- FIFogarty International CenterAwards: R03-TW006481, R03 TW006481-01, FIRCA R03-TW006481